Provided by Tiger Trade Technology Pte. Ltd.

Pacific Biosciences of California

1.63
+0.05003.16%
Post-market: 1.640.0098+0.60%17:58 EST
Volume:7.65M
Turnover:12.59M
Market Cap:492.11M
PE:-0.89
High:1.71
Open:1.59
Low:1.54
Close:1.58
52wk High:2.73
52wk Low:0.8511
Shares:301.91M
Float Shares:298.17M
Volume Ratio:0.93
T/O Rate:2.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8215
EPS(LYR):-1.8215
ROE:-213.45%
ROA:-34.09%
PB:92.00
PE(LYR):-0.89

Loading ...

Pacific Biosciences of California Inc. Publishes Q4 2025 MD&A Report

Reuters
·
Yesterday

Pacific Biosciences (PACB) Gets a Buy from Canaccord Genuity

TIPRANKS
·
Feb 13

PacBio Q4 revenue rises 14% driven by strong consumable sales

Reuters
·
Feb 13

Pacific Biosciences Q4 Adj. EPS $(0.12) Beats $(0.15) Estimate, Sales $44.645M Beat $42.530M Estimate

Benzinga
·
Feb 13

PacBio Q4 Vega system placements surge to 42 units, up 6x year-on-year

Reuters
·
Feb 13

BRIEF-Pacific Biosciences of California Q4 Adjusted Net Income USD -37.6 Million Vs. IBES Estimate USD -44.3 Million

Reuters
·
Feb 13

Pacific Biosciences of California Q4 Adjusted Gross Profit USD 17.8 Million

THOMSON REUTERS
·
Feb 13

Pacific Biosciences of California Inc Qtrly Adj EPS $-0.12

THOMSON REUTERS
·
Feb 13

PacBio Joins iHope Initiative to Advance Long-Read Genomic Sequencing for Rare Disease

Reuters
·
Feb 12

Pacific Biosciences Shifts Key Executive Responsibilities in Leadership Reshuffle

Reuters
·
Feb 04

Pacific Biosciences of California Closes $48.1 Million Sale of DNA Sequencing Assets to Illumina

MT Newswires Live
·
Feb 02

Pacific Biosciences of California Inc - Received $48.1 Mln in Net Cash Proceeds

THOMSON REUTERS
·
Feb 02

Pacbio Completes Sale of Short-Read Sequencing Assets

THOMSON REUTERS
·
Feb 02

Press Release: PacBio Completes Sale of Short-Read Sequencing Assets

Dow Jones
·
Feb 02

Pacific Biosciences of California Inc. to Report Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Jan 28

PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

GlobeNewswire
·
Jan 28

PacBio to Collaborate With n-Lorem Foundation and EspeRare on Precision Therapies for Rare Diseases

Reuters
·
Jan 12

PacBio Reports Preliminary 2025 Revenue of $160 Million with 4% Year-Over-Year Growth

Reuters
·
Jan 12

PacBio HiFi Sequencing Adopted as First-Line Tool for SUDC Research

Reuters
·
Jan 12

Pacific Biosciences of California Inc - Announces Prelim Q4 2025 Revenue of $44.6 Mln

THOMSON REUTERS
·
Jan 12